Literature DB >> 16209277

Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect.

Kyung-Chul Yoon1, Hwan Heo, In-Young Jeong, Yeoung-Geol Park.   

Abstract

PURPOSE: To evaluate the therapeutic effect of umbilical cord serum in the treatment of persistent epithelial defect of the cornea.
METHODS: Fourteen eyes of 14 patients with persistent epithelial defect that had persisted for at least 2 weeks despite conventional treatment were treated with 20% umbilical cord serum eyedrops six times a day. The images of the epithelial defects were captured using a camera attached to a slit lamp biomicroscope and the areas of the epithelial defects were calculated. Treatment was considered effective for epithelial defect healing within 2 weeks, partially effective for healing within 2 to 4 weeks, and ineffective for healing requiring either more than 1 month or additional measures.
RESULTS: Mean duration of epithelial defect before treatment was 7.2 +/- 6.3 weeks, and mean area was 7.86 +/- 7.32 mm2. Umbilical cord serum therapy was effective in 6 eyes (42.9%), partially effective in 6 (42.9%), and ineffective in 2 (14.2%). Nevertheless, the epithelial defects in both the ineffective eyes were eventually healed within 8 weeks. Mean healing time in effective or partially effective cases was 2.75 +/- 1.06 weeks.
CONCLUSIONS: The use of umbilical cord serum eyedrops for the treatment of persistent epithelial defect is effective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209277     DOI: 10.3341/kjo.2005.19.3.174

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  11 in total

Review 1.  Regenerative Therapy Using Umbilical Cord Serum.

Authors:  Nagarajan Maharajan; Gwang-Won Cho; Ji Hyun Choi; Chul Ho Jang
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

2.  Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects.

Authors:  Elif Erdem; Meltem Yagmur; Inan Harbiyeli; Hande Taylan-Sekeroglu; Reha Ersoz
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 3.  Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches.

Authors:  Sunali Goyal; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

Review 4.  [Autologous serum and alternative blood products for the treatment of ocular surface disorders].

Authors:  G Geerling; J D Unterlauft; K Kasper; S Schrader; A Opitz; D Hartwig
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

Review 5.  Use of umbilical cord serum in ophthalmology.

Authors:  Kyung Chul Yoon
Journal:  Chonnam Med J       Date:  2014-12-17

6.  Effects of Topical 1% Sodium Hyaluronate and Hydroxypropyl Methylcellulose in Treatment of Corneal Epithelial Defects.

Authors:  Kourosh Shahraki; Seyed-Rafi Hosseini; Atefeh Amini Fard; Hashem Shademan; Kianoush Shahraki; Amir Masood Salari; Mohammad-Naeim Amini Fard
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2016

Review 7.  Application of Novel Drugs for Corneal Cell Regeneration.

Authors:  Sang Beom Han; Yu-Chi Liu; Karim Mohamed-Noriega; Jodhbir S Mehta
Journal:  J Ophthalmol       Date:  2018-05-02       Impact factor: 1.909

Review 8.  Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.

Authors:  Federico Bernabei; Matilde Roda; Marina Buzzi; Marco Pellegrini; Giuseppe Giannaccare; Piera Versura
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

Review 9.  Topical Umbilical Cord Serum for Corneal Epithelial Defects after Diabetic Vitrectomy.

Authors:  Siamak Moradian; Marzieh Ebrahimi; Azade Kanaani; Amir Faramarzi; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-04-06

Review 10.  Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review.

Authors:  Giuseppe Giannaccare; Adriano Carnevali; Carlotta Senni; Laura Logozzo; Vincenzo Scorcia
Journal:  Ophthalmol Ther       Date:  2020-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.